欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
NL/H/4511/001
药品名称
Xifaxanta
活性成分
rifaximin 550.0 mg
剂型
Film-coated tablet
上市许可持有人
Norgine B.V. Antonio Vivaldistraat 150 1083 HP Amsterdam
参考成员国 - 产品名称
Netherlands (NL)
互认成员国 - 产品名称
United Kingdom (Northern Ireland) (XI)
PL 20011/0020 - 0018
Germany (DE)
XIFAXAN 550 mg Filmtabletten
Denmark (DK)
Xifaxan
Belgium (BE)
Luxembourg (LU)
Ireland (IE)
Spain (ES)
Italy (IT)
Sweden (SE)
Norway (NO)
Xifaxan
Finland (FI)
许可日期
2012/11/29
最近更新日期
2024/08/12
药物ATC编码
A07AA11 rifaximin
申请类型
TypeLevel1:
[not specified]
TypeLevel2:
[not specified]
TypeLevel3:
[not specified]
TypeLevel4:
[not specified]
TypeLevel5:
[not specified]
附件文件下载
PubAR
|
190806 NL_H_4511_001_DC Xifaxan PAR
Date of last change:2024/09/06
Final PL
|
Common PIL
Date of last change:2024/09/06
Final Product Information
|
common_pil_targaxan_clean
Date of last change:2024/09/06
Final Product Information
|
common_spc_targaxan_clean
Date of last change:2024/09/06
Final SPC
|
common_spc_xif_en_clean
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase